Author

C. Armon

Institutions: Centers for Disease Control and Prevention, Cerner (United States)

Observed institutions: Centers for Disease Control and Prevention, Mayo Clinic, Baystate Medical Center, Emory University, Cerner (United States), Medical College of Wisconsin, University of Michigan, Hennepin County Medical Center, Mayo Clinic in Arizona

OpenAlex ID: A5010260686

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

2008 · E. J. Sorenson, A. J. Windbank, et al. · Neurology · 243

Seasonal Influenza Vaccination Rates in the HIV Outpatient Study--United States, 1999-2013

2014 · M. D. Durham, M. D. Durham, et al. · Clinical Infectious Diseases · 14

Works count: 3

Citation count: 271

H-index: 3

I10-index: 3